Sub 5c now on sell side. We go down on bad ASX days, and also down on good ASX days.... consistently. This is causing shareholders a lot of grief. I attribute 90% of the continued decline to the lack of any meaningful ( non-fluffy) comment from management on the current trials. Other biotechs sometimes provide "interim" data with the caveat that trials are not complete so a definitive outcome cannot be provided until trialling is complete. I'd settle for that for the time being.
Sub 5c now on sell side. We go down on bad ASX days, and also...
-
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
